|
Renal Cell Carcinoma Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 167 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Renal Cell Carcinoma Global Clinical Trials Review, H1, 2012" provides data on the Renal Cell Carcinoma clinical trial scenario. This report provides.....
Introduction GlobalData's clinical trial report, “Renal Cell Carcinoma Global Clinical Trials Review, H1, 2012" provides data on the Renal Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Cell Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 7 Introduction 8 Renal Cell Carcinoma 8 Report Guidance 8 Clinical Trials by Region 9 Clinical Trials by Country 10 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12 Top Five Countries Contributing to Clinical Trials in Europe 13 Top Countries Contributing to Clinical Trials in North America 14 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15 Top Five Countries Contributing to Clinical Trials in Central and South America 16 Clinical Trials by BRIC Nations 17 Clinical Trials by G7 Nations 18 Clinical Trials in G7 Nations by Trial Status 19 Clinical Trials by E7 Nations 20 Clinical Trials in E7 Nations by Trial Status 21 Clinical Trials by Phase 22 In Progress Trials by Phase 23 Clinical Trials by Trial Status 24 Unaccomplished Trials of Renal Cell Carcinoma 25 Subjects Recruited Over a Period of Time 30 Prominent Sponsors 31 Top Companies Participating in Renal Cell Carcinoma Therapeutics Clinical Trials 33 Prominent Drug Comparison 35 Clinical Trial Profiles 36 Clinical Trial Overview of Top Companies 36 Pfizer Inc. 36 Clinical Trial Overview of Pfizer Inc. 36 GlaxoSmithKline plc 39 Clinical Trial Overview of GlaxoSmithKline plc 39 Novartis AG 41 Clinical Trial Overview of Novartis AG 41 Bayer AG 43 Clinical Trial Overview of Bayer AG 43 Amgen Inc. 45 Clinical Trial Overview of Amgen Inc. 45 Bristol-Myers Squibb Company 46 Clinical Trial Overview of Bristol-Myers Squibb Company 46 F. Hoffmann-La Roche Ltd. 47 Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 47 AVEO Pharmaceuticals, Inc. 48 Clinical Trial Overview of AVEO Pharmaceuticals, Inc. 48 Agenus, Inc. 49 Clinical Trial Overview of Agenus, Inc. 49 Eli Lilly and Company 50 Clinical Trial Overview of Eli Lilly and Company 50 Argos Therapeutics, Inc. 51 Clinical Trial Overview of Argos Therapeutics, Inc. 51 Celgene Corporation 52 Clinical Trial Overview of Celgene Corporation 52 AstraZeneca PLC 53 Clinical Trial Overview of AstraZeneca PLC 53 Bayer HealthCare AG 54 Clinical Trial Overview of Bayer HealthCare AG 54 Abbott Laboratories 55 Clinical Trial Overview of Abbott Laboratories 55 Genzyme Corporation 56 Clinical Trial Overview of Genzyme Corporation 56 Genentech, Inc. 57 Clinical Trial Overview of Genentech, Inc. 57 Astellas Pharma Inc. 58 Clinical Trial Overview of Astellas Pharma Inc. 58 Active Biotech AB 59 Clinical Trial Overview of Active Biotech AB 59 Clinical Trial Overview of Top Universities / Institutes / Hospitals 60 The University of Texas M. D. Anderson Cancer Center 60 Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 60 Memorial Sloan Kettering Cancer Center 62 Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 62 Beth Israel Deaconess Medical Center 63 Clinical Trial Overview of Beth Israel Deaconess Medical Center 63 Sarah Cannon Research Institute 64 Clinical Trial Overview of Sarah Cannon Research Institute 64 University Health Network 65 Clinical Trial Overview of University Health Network 65 Roswell Park Cancer Institute 66 Clinical Trial Overview of Roswell Park Cancer Institute 66 Case Comprehensive Cancer Center 67 Clinical Trial Overview of Case Comprehensive Cancer Center 67 UCLA's Jonsson Comprehensive Cancer Center 68 Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 68 Radboud University 69 Clinical Trial Overview of Radboud University 69 Seoul National University Hospital 70 Clinical Trial Overview of Seoul National University Hospital 70 Cambridge University Hospitals NHS Foundation Trust 71 Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust 71 The Methodist Hospital System 72 Clinical Trial Overview of The Methodist Hospital System 72 Duke University 73 Clinical Trial Overview of Duke University 73 Assistance Publique - Hopitaux de Paris 74 Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 74 Stanford University 75 Clinical Trial Overview of Stanford University 75 University of Colorado 76 Clinical Trial Overview of University of Colorado 76 Kobe University 77 Clinical Trial Overview of Kobe University 77 Kidney Cancer Research Bureau 78 Clinical Trial Overview of Kidney Cancer Research Bureau 78 St. Joseph's Healthcare Hamilton 79 Clinical Trial Overview of St. Joseph's Healthcare Hamilton 79 Abramson Cancer Center 80 Clinical Trial Overview of Abramson Cancer Center 80 Five Key Clinical Profiles 81 Appendix 163 Abbreviations 163 Definitions 163 Research Methodology 165 Secondary Research 165 About GlobalData 166 Contact Us 166 Disclaimer 166 Source 167 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9 Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Renal Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12 Renal Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13 Renal Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2012* 14 Renal Cell Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 15 Renal Cell Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16 Renal Cell Carcinoma Therapeutics Clinical Trials, BRIC Countries, 2012* 17 Renal Cell Carcinoma Therapeutics Clinical Trials, G7 Countries, 2012* 18 Renal Cell Carcinoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Renal Cell Carcinoma Therapeutics Clinical Trials, E7 Countries, 2012* 20 Renal Cell Carcinoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22 Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23 Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Renal Cell Carcinoma Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25 Renal Cell Carcinoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26 Renal Cell Carcinoma Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27 Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 30 Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 32 Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 34 Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 35 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 36 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 39 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 41 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 43 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 45 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 46 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 47 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AVEO Pharmaceuticals, Inc., 2012* 48 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Agenus, Inc., 2012* 49 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 50 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Argos Therapeutics, Inc., 2012* 51 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 52 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 53 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer HealthCare AG, 2012* 54 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 55 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2012* 56 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012* 57 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012* 58 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Active Biotech AB, 2012* 59 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 60 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 62 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2012* 63 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012* 64 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012* 65 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 66 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 67 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2012* 68 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012* 69 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012* 70 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2012* 71 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Methodist Hospital System, 2012* 72 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 73 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 74 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 75 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2012* 76 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2012* 77 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kidney Cancer Research Bureau, 2012* 78 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Joseph's Healthcare Hamilton, 2012* 79 Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012* 80 List of Figures Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9 Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Renal Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12 Renal Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13 Renal Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14 Renal Cell Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 15 Renal Cell Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16 Renal Cell Carcinoma Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17 Renal Cell Carcinoma Therapeutics Clinical Trials, G7 Countries (%), 2012* 18 Renal Cell Carcinoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Renal Cell Carcinoma Therapeutics Clinical Trials, E7 Countries (%), 2012* 20 Renal Cell Carcinoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22 Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23 Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 30 Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 31 Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 33 Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 35 GlobalData Methodology 165 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
